Back

Metabolic dysfunction in arrhythmogenic cardiomyopathy: a cardiopulmonary exercise testing and metabolomics study

9 May 2026 (11:30 - 12:00)
Organised by: Logo
Congress Presentation Part of: Advanced phenotyping and risk stratification in inherited cardiomyopathies Clinical HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Giulia De Zan

University Medical Center Utrecht, Utrecht (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Echocardiographic post-systolic shortening patterns correlate with ventricular arrhythmias and heart failure in desmoplakin associated cardiomyopathy: a multimodality imaging study
Mr A. Salavati (Utrecht, NL)
Abstract Slides
Presentation thumbnail
Left bundle branch block in dilated and non-dilated left ventricular cardiomyopathy: relation to genetics, imaging and endomyocardial biopsy
Doctor L. Bianchi (Maastricht, NL)
Abstract Slides
Presentation thumbnail
Nutritional status and body composition in patients with Fabry disease in comparison to hypertrophic cardiomyopathy
Mr K. Gorniak (Wroclaw, PL)
Abstract Slides
Presentation thumbnail
Two dimensional strain echocardiography for risk stratification in Desmoplakin cardiomyopathy
Doctor A. Dupart (Nantes, FR)
Abstract Slides

Access the full session

Session thumbnail
Advanced phenotyping and risk stratification in inherited cardiomyopathies

The Event

Event poster

Heart Failure 2026

9 May 2026 11:30 CET
You may be interested in
thumbnail
Congress Presentation
Metabolic changes in titin cardiomyopathy
22 May 2022
thumbnail
Congress Presentation
Cardiopulmonary exercise testing as a diagnostic marker for exercise-induced myocardial ischemia
30 August 2025
thumbnail
Congress Presentation
Fat metabolism during maximal exercise test in children and adults athletes
4 April 2025
thumbnail
Congress Presentation
The influence of exercise modality and intensity on ventricular arrhythmia burden and perception of effort in patients with Arrhythmogenic Right Ventricular Cardiomyopathy with plakophilin-2 variants
31 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources